share_log

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying

Benzinga ·  Sep 9 21:13

The Dow Jones index closed lower by more than 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Neuronetics

  • The Trade: Neuronetics, Inc (NASDAQ:STIM) Director Glenn P Muir bought a total of 25,000 shares at an average price of $0.80. To acquire these shares, it cost around $20,000.
  • What's Happening: On Aug. 12, Neuronetics reported worse-than-expected second-quarter financial results and issued third-quarter revenue guidance below estimates.
  • What Neuronetics Does: Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

ConnectM Technology Solutions

  • The Trade: ConnectM Technology Solutions, Inc. (NASDAQ:CNTM) Mahesh Choudhury acquired a total of 69,542 shares at at an average price of $0.89. To acquire these shares, it cost around $61,892.
  • What's Happening: On Aug. 13, ConnectM Technology Solutions posted a second-quarter loss of 39 cents per share.
  • What ConnectM Technology Solutions Does: ConnectM Technology Solutions Inc is a clean energy technology and solutions provider.

Retractable Technologies

  • The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 5,251 shares at an average price of $0.91. The insider spent around $4,799 to buy those shares.
  • What's Happening: On Aug. 14, Retractable Technologies posted a wider quarterly loss.
  • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.
  • Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment